(1) Review the unique nutritional needs of preterm infants (2) Review the incidence and causes of extrauterine growth restriction (EUGR) in VLBW infants (3) Summarize the evidence regarding the impact of nutrition on neurodevelopmental outcomes (4) Define the protein and energy requirements of VLBW infants (5) Discuss a variety of nutritional strategies for meeting protein and energy requirements of VLBW infants
Cathy Laarman, NICU Dietitian in Grand Rapids, Michigan
In the next webinar series from the Nutritional Advisory Committee, Cathy Laarman, RD will provide an overview on how to identify signs and symptoms of Cow's Milk Protein Allergy, review the guidelines for diagnosing CPMA and the appropriate nutritional intervention to treat an infant with CPMA.
Amy B. Hair, MD. Section of Neonatology, Department of Pediatrics at Texas Children’s Hospita
Review the study and findings from the "Randomized Trial of Human Milk Cream as a Supplement to Standard Fortification of an Exclusive Human Milk-Based Diet in Infants 750-1250 g Birth Weight."
• Understand how 100% human milk feeding supports long term and short term benefits for preterm infants
• Discuss the caloric variation in human milk and implications for achieving appropriate postnatal growth
• Review the objectives, design and outcomes of the randomized clinical trial
Our mission is to make a meaningful difference in the lives of thousands of the most vulnerable infants through world class research and innovative products.
Prolacta Bioscience is a privately held, life sciences company dedicated to improving the quality of life in the most fragile infants through the harmony of nature and science. We create specialty formulations made from human milk for the nutritional needs of premature infants in neonatal intensive care units (NICU). These formulations are sold to NICUs around the country.